-Reuters
Cowen & Co. Maintains Outperform on MYT Netherlands Parent, Lowers Price Target to $17
Cowen & Co. analyst Oliver Chen maintains MYT Netherlands Parent (NYSE:MYTE) with a Outperform and lowers the price target from $22 to $17.
Related Posts
TriNet Announces Acquisition Of Clarus R+D Solutions LLC; Terms Not Disclosed
Addition of Fintech Solutions Company Expands Solution Offering and Provides SMB Customers a Simplified R&D Tax Credit Process
DUBLIN, Calif., Sept. 6, 2022 /PRNewswire/ -- TriNet,
Aclarion Announces Signing Of Commercial Agreement With Porter Hospital, An AdventHealth facility, To Bring Nociscan Technology To Denver
Porter Hospital Becomes First Facility in Denver to Give Chronic Low Back Pain Patients Access to Revolutionary Nociscan Technology That Measures Biomarkers to Pinpoint the Source of PainGeorge Frey, MD Becomes